Medicine
Ogsiveo 100 mg tablet
Ogsiveo 100 mg tablet is a prescription medicine containing Nirogacestat for oral use, marketed by SpringWorks Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Nirogacestat
- Brand
- Ogsiveo
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 14 tablets
- Marketing authorisation holder
- SpringWorks Therapeutics
- Manufacturer
- SpringWorks Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to 30°C (59°F to 86°F). See USP Controlled Room Temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XX81 Nirogacestat
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 November 2023
- Identifiers
- RxCUI 2680360, 2680362, 2680363 +5DailyMed set ID f172e6ff-3190-41b0-b95a-58a7ef9e9e1eNDC 82448-100Application NDA217677
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 14 tablet, film coated in 1 blister pack | 82448-100-14 | SpringWorks Therapeutics | 27 November 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nirogacestat
Clinical summary
Nirogacestat is a gamma secretase inhibitor indicated for adult patients with progressing desmoid tumors who require systemic treatment. It is available as tablets for oral use. MedsAcross supplies Nirogacestat for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NirogacestatFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OGSIVEO prescribing information (SpringWorks Therapeutics) · U.S. National Library of Medicine, DailyMed
- Ogsiveo: European public assessment report (EPAR) · European Medicines Agency
Need Ogsiveo 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.